Skip to main content
Premium Trial:

Request an Annual Quote

Epigenetic Signature of Aging Also Found Among Tumor Tissues

Researchers have uncovered an epigenetic signature that is common to both aging and cancer, as they report in Science Advances. While somatic mutations that arise as cells divide contribute to aging-related cancer risk, researchers from Yale University School of Medicine note that DNA methylation can also change as cells divide and may also contribute to oncogenic transformation. Using immortalized fetal astrocytes, the researchers identified DNA methylation changes that occur with replication, which they used to establish the Cellular Division and Replication Induced FingerprinT, or CellDRIFT, signature. By analyzing this signature in a rage of tissue types, both cancerous and non-cancerous, the researchers found that it increased with age and could distinguish tumor tissue from healthy. "While tissue-specific stem cell division rates may set a baseline risk of cancer development in various tissues, individual differences in cancer risk may not be entirely luck based and instead might in part reflect differential epigenetic aging rates," the researchers write. "Hence, there is a need for research into interventions to slow or reverse the accumulation of epigenetic changes with age."

Epigenetics, in the journals, Scan

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.